Pancreatic Cancer Research

ResearcherNankai UniversityActive in the last 2 years

Hongkai Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2186-5508; OpenAlex author ID A5100721817. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper

Papers 7

  1. Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. Last author DOI 10.1136/jitc-2025-013175↗
  2. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2024.149931↗
  3. Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer. Co-author DOI 10.1186/s12951-024-02369-9↗
  4. Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Co-author DOI 10.1016/j.omto.2023.08.011↗
  5. OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. Co-author DOI 10.7150/thno.83495↗
  6. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell… Co-author DOI 10.1136/jitc-2021-003809↗
  7. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ymthe.2020.10.027↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Youjia Cao · 5 shared papers, 2021–2025 · strength 0.77
  2. Shiyu Liu · 4 shared papers, 2022–2025 · strength 0.61
  3. Cuizhu Zhang · 3 shared papers, 2021–2024 · strength 0.45
  4. Ruikun Wang · 3 shared papers, 2021–2023 · strength 0.39
  5. Feilong Zhou · 2 shared papers, 2024–2025 · strength 0.38
  6. Jiliang Zhao · 2 shared papers, 2024 · strength 0.37
  7. Mingjuan Du · 2 shared papers, 2023 · strength 0.29
  8. Fan Li · 1 shared paper, 2025 · strength 0.19
  9. Jie Wang · 1 shared paper, 2025 · strength 0.19
  10. Yuanke Li · 1 shared paper, 2025 · strength 0.19
  11. Zhaoyuan Zhang · 1 shared paper, 2025 · strength 0.19
  12. Haoqi Zhang · 1 shared paper, 2024 · strength 0.18
  13. Xinglu Huang · 1 shared paper, 2024 · strength 0.18
  14. Yuan Wang · 1 shared paper, 2023 · strength 0.13
  15. Wenrui Gao · 1 shared paper, 2023 · strength 0.13
  16. Wei Wang · 1 shared paper, 2023 · strength 0.13
  17. Liming Zhang · 1 shared paper, 2021 · strength 0.12
  18. Nianchao Zhang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.